EMCDDA Home
  • EN
Search

Buprenorphine — treatment, misuse and prescription practices

EMCDDA, Lisbon, November 2005

Publication type:

Selected issues

Summary:

Since the mid-1990s buprenorphine has increasingly become available in Europe as an alternative to methadone for the treatment of opiate dependence. In this Selected issue, the reasons why clinicians are attracted to this drug, as well as the costs and benefits of buprenorphine in comparison with other treatment options, are explored in detail, and, for the first time, the increasing popularity of buprenorphine for the treatment of opiate dependence in many European countries is documented.

Download as pdf (0.6 MB):

English (en)

Table of contents

  • Legislation and pharmacological action
  • Treatment provision of buprenorphine
  • Misuse of buprenorphine

Pages:

16

Price:

free

ISBN/ISSN:

92-9168-246-2

Catalogue number:

TDAF05001ENC

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 20 August 2010